Trials / Completed
CompletedNCT01659398
Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Patrick Moriarty, MD, FACP, FACC · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate whether enhanced external counterpulsation (EECP) therapy for 7 consecutive weeks will improve cerebral blood flow and possibly over time enhance or slow down breakdown of cognitive function in patients diagnosed with mild cognitive impairment (MCI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | External Counterpulsation (EECP) | A noninvasive neuroimaging technique. Administration of 35 hours EECP therapy over a 7 week period. EECP to be administered for 1 hour, 5 times a week. |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2012-08-07
- Last updated
- 2016-01-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01659398. Inclusion in this directory is not an endorsement.